PATH | VRL
Menu

Safety and Efficacy of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine

This study, published in The New England Journal of Medicine, evaluated the safety and efficacy of Merck’s rotavirus vaccine (RotaTeq®), with a focus on determining risk of intussusception.

Author: Vesikari T, Matson D, Dennehy P, et al.

Published: 2006

» Visit web page (English)

(Located at content.nejm.org)

Citation: Vesikari T, Matson D, Dennehy P, et al. Safety and Efficacy of a Pentavalent Human-bovine (WC3) Reassortant Rotavirus Vaccine. New England Journal of Medicine. 2006;354(1):23-33.

» Download file (French)

221 KB PDF

Also known as: Sécurité et efficacité d’un vaccin pentavalent contre le rotavirus humain–bovin réassorti (WC3)

» Download file (Russian)

254 KB PDF

Also known as: Безопасность и эффективность пятивалентной человеческой–бычьей (WC3) реассортативной антиротавирусной вакцины

» Download file (Spanish)

216 KB PDF

Also known as: Seguridad y eficacia de una vacuna antirrotavírica reagrupada humano–bovina (WC3) pentavalente

Resource types: Peer-reviewed journal

Diseases/vaccines: Rotavirus

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Global